Earable Neuroscience

Earable Neuroscience is a deep tech company specializing in consumer wearables that enhance cognitive functions, focusing particularly on improving sleep quality. The company's flagship product, the FRENZ Brainband, is an AI-powered sleep-aid wearable that uses bone-conduction speakers to track and stimulate brain activity, aiding in better sleep, focus, and relaxation.

This FRENZ Brainband along with the FRENZ application provides real-time sleep scoring and bone conduction to deliver cognitive behavioral therapy (CBT) audio sessions that are specific to each user. By measuring the brainwaves of wearers, the device delivers personalized audio stimulations in real time, promoting better sleep quality. The product development spanned nine years and involved collaborations with the University of Colorado and the University of Oxford, earning 18 patents in the process.

The company operates a manufacturing and selling business model for its brainband. As of April 2024, the wearable device was priced at USD 490.

Key customers and partnerships

Earable Neuroscience's primary product, the FRENZ Brainband, targets consumers suffering from sleep disorders.

In October 2023, the company partnered with the Vietnamese Sleep Medicine Association to leverage the scientific research and Earable's expertise to further develop the FRENZ Brainband for wider adoption within Vietnam and globally. Earlier in March 2023, the company also partnered with Excelpoint Technology to expedite the commercialization of the FRENZ Brainband.

Funding and Financials

In June 2023, Earable raised an undisclosed amount through a Convertible Note funding round led by Samsung Ventures. The company also raised USD 6.6 million in January 2022, through a seed funding round led by Smilegate Investment and Founders Fund, to continue to expand its operations and support its development efforts.